6533b828fe1ef96bd1288fe0

RESEARCH PRODUCT

Heterogeneity of P2-Purinoceptors in Brain Circulation

Germán TorregrosaCristina AlvarezJuan B. SalomEnrique AlborchJ. MirandaJosé A. Alabadí

subject

P2Y receptorGoatsIndomethacinPurinergic receptorCerebral arteriesReceptors PurinergicCerebral ArteriesBiologyPharmacologyCerebral circulationAdenosine TriphosphateNeurologyVasoconstrictionCerebrovascular Circulationmedicine.arteryAnesthesiaMiddle cerebral arteryCirculatory systemmedicineAnimalsPotencyFemaleNeurology (clinical)Cardiology and Cardiovascular MedicineReceptor

description

The existence of P2-purinoceptors in the cerebrovascular bed was examined by testing the effects of ATP and its stable analog, α,β-methylene-ATP, on CBF in the unanesthetized goat as well as on isometric tension in isolated goat middle cerebral artery. When injected directly into the cerebral circulation, ATP increased and α,β-methylene-ATP decreased CBF. Indomethacin did not modify either of these effects. The vasoconstrictor action of α,β-methylene-ATP was reduced by nicardipine. “In vitro,” both ATP and α,β-methylene-ATP contracted the cerebral arteries at resting tone, but the analog was more potent than ATP. Repeated application of α,β-methylene-ATP as well as indomethacin significantly reduced the ATP-induced contractions. Nicardipine inhibited both the α,β-methylene-ATP- and the ATP-induced contractile response. In preconstricted arteries, ATP produced relaxation and α,β-methylene-ATP induced further contraction. The relaxant response to ATP was not modified by indomethacin. These results show the existence of two subtypes of P2-purinoceptors in brain circulation: P2x, more sensitive to α,β-methylene-ATP than to ATP, which elicits cerebral vasoconstriction; and P2y, sensitive to ATP, which elicits cerebral vasodilation.

https://doi.org/10.1038/jcbfm.1990.100